Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

GelTex's RenaGel enters phase III

June 21, 1996

NS-21 licensing options awarded

June 21, 1996

Alpha1-adrenoceptor antagonists described

June 21, 1996

Flomax MR approved for U.K. market

June 14, 1996

Patient enrollment initiated for SYNSORB Pk

June 7, 1996

TZA-2209: A pure aromatase inhibitor

June 7, 1996

Yamanouchi reports vasopressin V1 receptor antagonists

May 31, 1996

L-Arginine shows promise in treatment of interstitial cystitis

May 24, 1996

PPS + oxybutinin for interstitial cystitis

May 24, 1996

Lovastatin potential for use in post-transplant patients

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...